EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Screening for and surveillance of premalignant conditions of the stomach

Irina Luzko, Leticia Moreira, Jan Bornschein

Best Practice & Research Clinical Gastroenterology · 2025

DOI: 10.1016/j.bpg.2025.101978 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2025. Verfasst von Irina Luzko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), CIBEREH…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Precancerous Conditions, Early Detection of Cancer, Mass Screening. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, UK Research and Innovation Medical Research Council, Carlos III Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Strategies for population-based screening are thus far only implemented in high incidence countries such as South Korea or Japan with data showing a positive impact on gastric cancer mortality. Screening in most Western countries is deemed not cost-effective as these are mainly classified as low or intermediate risk regions. This is in part due to high costs for endoscopy as the diagnostic gold-standard. Blood testing for serum pepsinogens is implemented as a pre-screening tool in some Asian countries but can better highlight mucosal atrophy than the cancer itself. Endoscopic surveillance of patients with advanced preneoplastic conditions allows detection of early neoplastic lesions that can be treated endoscopically, resulting in better outcome, and is hence now also recommended by several European countries. However, there is no uniform approach, so screening and surveillance strategies need to take regional characteristics into account including gastric cancer incidence and cost for endoscopy among others.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsPrecancerous ConditionsEarly Detection of CancerMass ScreeningHumansGastroscopyPepsinogen AIncidencePopulation SurveillancePepsinogensRisk FactorsCost-Benefit Analysis

Stichwörter der Autor:innen

Early diagnosisGastric cancerScreeningSurveillance

Substanzen

Pepsinogen APepsinogens

Autor:innen und Institutionen

  • Department of Gastroenterology, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), CIBEREHD, Spain; Facultat de Medicina, Universitat de Barcelona, Barcelona, 0…
  • Medical Research Council Translational Immune Discovery Unit (MRC TIDU), Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, UK; Translational Gastroenterology and Liver Unit, John Radcliffe…

Förderung

  • Medical Research Council
  • UK Research and Innovation Medical Research Council
  • Carlos III Health Institute
  • Asociación Española de Gastroenterología

Zitieren

APA

Luzko, I., Moreira, L., & Bornschein, J. (2025). Screening for and surveillance of premalignant conditions of the stomach. Best Practice & Research Clinical Gastroenterology. https://doi.org/10.1016/j.bpg.2025.101978

Vancouver

Luzko I, Moreira L, Bornschein J. Screening for and surveillance of premalignant conditions of the stomach. Best Practice & Research Clinical Gastroenterology. 2025. doi:10.1016/j.bpg.2025.101978

BibTeX
@article{Luzko2025,
  author = {Luzko, Irina and Moreira, Leticia and Bornschein, Jan},
  title = {Screening for and surveillance of premalignant conditions of the stomach},
  journal = {Best Practice & Research Clinical Gastroenterology},
  year = {2025},
  doi = {10.1016/j.bpg.2025.101978}
}
Kostenlos starten →